MARCELLUSI, ANDREA
MARCELLUSI, ANDREA
Dipartimento di Scienze Farmaceutiche
High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma
2024 J. Pöhlmann, M. Weller, A. Marcellusi, K. Grabe-Heyne, L. Krott-Coi, S. Rabar, R. Pollock
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy
2024 F. Mennini, P. Sciattella, A. Marcellusi, F. Bartolini, F. Bernardi, F. Levrat-Guillen, M. Cozzolino, M. Di Gennaro, R. Giordana, M. Giustozzi, U. Trama
Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis
2024 A. Marcellusi, F. Mennini, M. Andreoni, L. Kondili
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy.
2024 G. Ghetti, F. Mennini, A. Marcellusi, M. Bischof, G. Pistillo, M. Pane
Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mNSCLC) and Melanoma in Italy.
2024 M. Paoletti, C. Bini, A. Marcellusi, F. Mennini
Impact of Chronic Coronary Artery Disease and Revascularization Strategy in Patients with Severe Aortic Stenosis Who Underwent Transcatheter Aortic Valve Implantation
2023 C. Aurigemma, M. Massussi, C. Fraccaro, M. Adamo, P. D'Errigo, S. Rosato, F. Seccareccia, G. Santoro, M. Baiocchi, M. Barbanti, F. Biancari, G. Baglio, A. Marcellusi, C. Trani, G. Tarantini
Financial Burden of Transcatheter Aortic Valve Implantation
2023 P. D'Errigo, A. Marcellusi, F. Biancari, M. Barbanti, F. Cerza, G. Tarantini, M. Ranucci, G. Ussia, G. Costa, G. Badoni, C. Fraccaro, F. Meucci, G. Baglio, F. Seccareccia, C. Tamburino, S. Rosato
Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis
2023 G. Fabiano, A. Marcellusi, F.S. Mennini, P. Sciattella, G. Favato
One-Year Outcomes and Trends over Two Eras of Transcatheter Aortic Valve Implantation in Real-World Practice
2022 G. Costa, P. D'Errigo, S. Rosato, F. Biancari, A. Marcellusi, G. Tarantini, G. Santoro, M. Baiocchi, D. Maffeo, C. Fiorina, F. Cerza, G. Baglio, T. Juvonen, G. Badoni, R. Valvo, F. Seccareccia, M. Barbanti, C. Tamburino
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation
2022 A. Marcellusi, F. Mennini, M. Ruf, C. Galli, A. Aghemo, M. Brunetto, S. Babudieri, A. Craxi, M. Andreoni, L. Kondili
The Impact of COVID-19 Vaccination on the Italian Healthcare System: A Scenario Analysis
2022 A. Marcellusi, G. Fabiano, P. Sciattella, M. Andreoni, F.S. Mennini
HPV Vaccination during the COVID-19 Pandemic in Italy: Opportunity Loss or Incremental Cost
2022 F. Mennini, A. Silenzi, A. Marcellusi, M. Conversano, A. Siddu, G. Rezza
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
2022 A. Marcellusi, C. Simonelli, F. Mennini, L. Kondili
Health Technology Assessment (HTA) sull’introduzione di coorti aggiuntive per la vaccinazione contro il meningococco con vaccini quadrivalenti coniugati in Italia = Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy
2021 S. Boccalini, D. Panatto, F. Mennini, A. Marcellusi, C. Bini, D. Amicizia, P. Lai, R. Micale, D. Frumento, C. Azzari, S. Ricci, B. Bonito, G. DI Pisa, M. Iovine, L. Lodi, M. Giovannini, A. Moscadelli, S. Paoli, B. Pennati, L. Pisano, A. Bechini, P. Bonanni
Cross-regional variations of Covid-19 mortality in Italy: an ecological study
2021 C. Oliva, F. Di Maddaloni, A. Marcellusi, G. Favato
Addressing HCV Elimination Barriers in Italy: Healthcare Resource Utilization and Cost Impact Using 8 Weeks' Glecaprevir/Pibrentasvir Therapy
2021 M. Andreoni, G. Di Perri, M. Persico, A. Marcellusi, O. Ethgen, Y. Sanchez Gonzalez, M. Bondin, Z. Zhang, A. De Michina, R. Merolla, A. Craxì
The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries
2021 F. Mennini, A. Marcellusi, S. Robbins Scott, S. Montilla, A. Craxi, M. Buti, L. Gheorghe, S. Ryder, L. Kondili
Analisi dei costi associati ai pazienti con diabete di tipo 2 a rischio di malattia cardiovascolare aterosclerotica o con malattia cardiovascolare aterosclerotica accertata = Economic burden of diabetic patients with established atherosclerotic cardiovascular disease or risk factors for atherosclerotic cardiovascular disease
2021 A. Marcellusi, P. Sciattella, C. Bini, M. Rotundo, G. Aimaretti, F. Mennini
An analysis of the social and economic costs of breast cancer in Italy
2021 F.S. Mennini, M.T. Aurilio, S. Gazzillo, C. Nardone, P. Sciattella, A. Marcellusi, R. Migliorini, V. Sciannamea, A. Piccioni, M. Bolcato, S. Barni
One-Year Outcomes after Surgical versus Transcatheter Aortic Valve Replacement with Newer Generation Devices
2021 S. Rosato, F. Biancari, P. D'Errigo, M. Barbanti, G. Tarantini, F. Bedogni, M. Ranucci, G. Costa, T. Juvonen, G. Ussia, A. Marcellusi, G. Baglio, S. Cicala, G. Badoni, F. Seccareccia, C. Tamburino